ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 22:00
Director's Dealing
Long-Term Incentive Plan - grant of share options to primary insiders - Attachm…
English 1.5 MB
2025-11-10 22:00
Remuneration Information
Long-Term Incentive Plan - grant of share options to primary insiders
English 2.3 KB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 272.3 KB
2025-11-06 07:00
Quarterly Report
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 1.7 MB
2025-11-06 07:00
Investor Presentation
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 2.9 MB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 6.5 KB
2025-10-30 13:46
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 resu…
English 1.1 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 184.8 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 4.8 KB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 2.8 MB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
English 2.8 MB
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 776 bytes
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
Norwegian 693 bytes
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 205.9 KB
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 945 bytes

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArcticZymes Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.